Results 211 to 220 of about 213,754 (354)

Serum prolidase activity in patients with degenerative and rheumatic heart valve diseases

, 2010
Murat Bülent Rabuş, Recep Demirbağ, Yusuf Sezen, Mehmet Taşar, Abdullah Taşkın, Nurten Aksoy, Kaan Kırali, Cevat Yakut   +7 more
openalex   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Mortality rates and causes of death after cardiac interventions: real-world short- and long-term insights from the Netherlands. [PDF]

Neth Heart J
Derks L, Roefs MM, van Steenbergen GJ, Houterman S, van Veghel D.   +4 more
europepmc   +1 more source

Quadruple valve replacement in patients with carcinoid heart disease [PDF]

, 2010
Arman Arghami, Heidi M. Connolly, Martin Abel, Hartzell V. Schaff   +3 more
openalex   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Bioengineered heart valves for personalized therapy: advances in manufacturing and clinical challenges. [PDF]

Front Bioeng Biotechnol
Saeed M, Khan KA.
europepmc   +1 more source

Less Invasive Treatment of Heart Valve Disease [PDF]

, 2007
Manuel J. Antunes
openalex   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

Self-management measurement instruments specific to individuals with cardiovascular diseases: a systematic review protocol using COSMIN methodology. [PDF]

BMJ Open
Barbosa de Almeida JA, Monteiro KS, Santino TA, Florêncio RB, Fernandes ATDNSF, Peroni Gualdi L.   +5 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source